GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Green Planet Bioengineering Co Ltd (OTCPK:GPLB) » Definitions » Cash Flow from Financing

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Cash Flow from Financing : $0.04 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Green Planet Bioengineering Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Green Planet Bioengineering Co paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Green Planet Bioengineering Co spent $0.00 Mil on financial activities for the three months ended in Mar. 2024.


Green Planet Bioengineering Co Cash Flow from Financing Historical Data

The historical data trend for Green Planet Bioengineering Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Planet Bioengineering Co Cash Flow from Financing Chart

Green Planet Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.03 0.03 0.04

Green Planet Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Green Planet Bioengineering Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Green Planet Bioengineering Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Green Planet Bioengineering Co's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Planet Bioengineering Co  (OTCPK:GPLB) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Green Planet Bioengineering Co's issuance of stock for the three months ended in Mar. 2024 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Green Planet Bioengineering Co's repurchase of stock for the three months ended in Mar. 2024 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Green Planet Bioengineering Co's net issuance of debt for the three months ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Green Planet Bioengineering Co's net issuance of preferred for the three months ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Green Planet Bioengineering Co's cash flow for dividends for the three months ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Green Planet Bioengineering Co's other financing for the three months ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co received $0.00 Mil on other financial activities.


Green Planet Bioengineering Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Green Planet Bioengineering Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Planet Bioengineering Co (Green Planet Bioengineering Co) Business Description

Traded in Other Exchanges
N/A
Address
20807 Biscayne Boulevard, Suite 203, Aventura, FL, USA, 33180
Green Planet Bioengineering Co Ltd is a shell company.
Executives
Shanyan Ou director, officer: VP of Sales 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Jian Chen director, officer: Chief Scientist 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Jianrong Zheng director 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Zhao 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Yan Zhen 10 percent owner 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Cris Neely director, 10 percent owner, officer: President 18851 NE 29TH AVENUE, SUITE 700, AVENTURA CA 33180
Mondo Management Corp. 10 percent owner 61 BROADWAY, NEW YORK NY 10006
Gregory Sichenzia director, 10 percent owner SICHENZIA ROSS FRIEDMAN FERENCE LLP, 1065 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10018
Darrin M Ocasio director, 10 percent owner, officer: President C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006
Michael H Ference director, 10 percent owner, officer: Secretary C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Headlines

No Headlines